Related Experiment Video
Updated: May 16, 2026

Purification of Prominin-1+ Stem Cells from Postnatal Mouse Cerebellum
Published on: April 12, 2020
Gene Regulation of Prominin-1 (CD133) in Normal and Cancerous Tissues
Kouichi Tabu1, Norihisa Bizen, Tetsuya Taga
1Department of Stem cell Regulation, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, 113-8510, Tokyo, Japan, k-tabu.scr@mri.tmd.ac.jp.
Abstract:
A pentaspan membrane glycoprotein prominin-1 (frequently called CD133 in human) is widely used as a surface marker to identify and isolate normal stem/progenitor cells from various organs, although it is also expressed in some types of differentiated cells. Since CD133 was identified as a universal marker to isolate cancer stem cells (CSCs) in tumors derived from multiple tissues, much attention has been directed toward the relationship between its gene regulation and identity of CSCs (i.e., cancer stemness). Prominin-1 (PROM1) gene possesses five alternative promoters yielding multiple first exons within the 5'-untranslated region (UTR) and also splicing variants affecting the open reading frame (ORF) sequence, implicating the complicated gene regulation in a context-dependent manner. This chapter aims to organize the accumulated findings on prominin-1 with a focus on its altered expression and regulation in normal and cancerous cells and to discuss potential regulatory networks underlying cancer stemness.
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Negative Regulator Molecules
Regulation of Angiogenesis and Blood Supply
Positive Regulator Molecules

